Beryl Drugs Ltd vs Torrent Pharmaceuticals Limited

A side-by-side comparison of Beryl Drugs Ltd (BERYLDRUGSLTD) and Torrent Pharmaceuticals Limited (TORNTPHARM) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Torrent Pharmaceuticals Limited leads BERYLDRUGSLTD vs TORNTPHARM on 11 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability04
  • Growth02
  • Size & financial health13
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

19.60
P/E ratio
71.32
1.24
P/B ratio
22.29
0.00%
Dividend yield
0.77%
₹1.14
EPS
₹63.92

Profitability

TORNTPHARM takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

4.33%
Return on equity
25.78%
10.15%
Return on capital
13.91%
5.86%
EBITDA margin
32.61%
2.74%
Net margin
15.29%

Growth

TORNTPHARM takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

-11.16%
Revenue CAGR (3Y)
13.27%
-14.58%
Profit CAGR (3Y)
19.75%

Size & financial health

TORNTPHARM takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹11 Cr
Market cap
₹1.73L Cr
₹21 Cr
Revenue
₹13,980 Cr
₹1 Cr
Net profit
₹2,138 Cr
0.25
Debt / equity
1.79
Beryl Drugs Ltd
  • + ["Company has reduced debt.", "Debtor days have improved from 79.1 to 39.5 days.", "Company's working capital requirements have reduced from 55.1 days to 39.3 days"]
  • − ["Though the company is reporting repeated profits, it is not paying out dividend", "The company has delivered a poor sales growth of 6.60% over past five years.", "Promoter holding is low: 27.8%", "Company has a low return on equity of 6.42% over last 3 years."]
Torrent Pharmaceuticals Limited
  • + ["Company has a good return on equity (ROE) track record: 3 Years ROE 26.2%", "Company has been maintaining a healthy dividend payout of 67.6%"]
  • − ["Stock is trading at 20.67 times its book value", "Company has a high debt to equity ratio of 1.79."]
Beryl Drugs Ltd full analysis Torrent Pharmaceuticals Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

BERYLDRUGSLTD vs TORNTPHARM: Share Price, Valuation & Which to Buy | DocStoX